Yong Jin Lee Selected Research

Peptides (Polypeptides)

8/2016	New Glucocyclic RGD Dimers for Positron Emission Tomography Imaging of Tumor Integrin Receptors.
3/2015	Evaluation of a ⁶⁴Cu‑labeled 1,4,7‑triazacyclononane, 1‑glutaric acid‑4,7 acetic acid (NODAGA)‑galactose‑bombesin analogue as a PET imaging probe in a gastrin‑releasing peptide receptor‑expressing prostate cancer xenograft model.
12/2014	Improved tumor-targeting MRI contrast agents: Gd(DOTA) conjugates of a cycloalkane-based RGD peptide.
9/2014	Cyclic RGD Peptides Incorporating Cycloalkanes: Synthesis and Evaluation as PET Radiotracers for Tumor Imaging.
9/2014	Propylene cross-bridged macrocyclic bifunctional chelator: a new design for facile bioconjugation and robust (64)Cu complex stability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong Jin Lee Research Topics

Disease

64	Neoplasms (Cancer) 11/2023 - 02/2002
9	Hepatocellular Carcinoma (Hepatoma) 07/2016 - 09/2004
6	Prostatic Neoplasms (Prostate Cancer) 08/2023 - 03/2015
6	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2017
5	Inflammation (Inflammations) 01/2023 - 10/2010
5	Breast Neoplasms (Breast Cancer) 11/2019 - 10/2006
4	Anaplastic Thyroid Carcinoma 04/2013 - 11/2004
4	Colonic Neoplasms (Colon Cancer) 12/2010 - 07/2002
3	Myocardial Infarction 01/2024 - 07/2015
3	Brain Neoplasms (Brain Tumor) 11/2023 - 02/2002
3	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 09/2014
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023 - 08/2015
3	Infections 08/2012 - 10/2011
3	Glioma (Gliomas) 11/2010 - 02/2002
2	Lung Neoplasms (Lung Cancer) 01/2023 - 11/2009
2	Body Weight (Weight, Body) 01/2023 - 01/2022
2	Stomach Neoplasms (Stomach Cancer) 12/2022 - 02/2019
2	Wounds and Injuries (Trauma) 01/2022 - 01/2016
2	Carcinogenesis 12/2019 - 02/2008
2	Esophageal Squamous Cell Carcinoma 10/2018 - 01/2016
2	Edema (Dropsy) 10/2011 - 03/2011
1	Infarction (Infarctions) 01/2024
1	Fibrosis (Cirrhosis) 01/2023

Drug/Important Bio-Agent (IBA)

13	sodium-iodide symporter (sodium iodide symporter)IBA 07/2015 - 07/2002
10	Radioisotopes (Radionuclides)IBA 01/2018 - 09/2004
8	AcidsIBA 12/2022 - 07/2004
7	RadiopharmaceuticalsIBA 01/2023 - 01/2016
7	Therapeutic UsesIBA 01/2020 - 07/2007
6	GadoliniumIBA 09/2021 - 02/2013
5	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 08/2023 - 08/2016
5	Liposomes (Liposome)IBA 01/2021 - 11/2004
5	Peptides (Polypeptides)IBA 08/2016 - 09/2014
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 08/2023 - 02/2013
4	Chelating AgentsIBA 08/2023 - 01/2016
4	AntigensIBA 01/2023 - 12/2020
4	Thymidine KinaseIBA 02/2020 - 04/2010
4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2010 - 12/2004
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2024 - 02/2002
3	RNA (Ribonucleic Acid)IBA 02/2020 - 12/2010
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 12/2019 - 10/2018
3	ErbB Receptors (EGF Receptor)IBA 02/2019 - 11/2017
3	IntegrinsIBA 01/2019 - 02/2013
3	Cetuximab (Erbitux)FDA Link 10/2018 - 01/2016
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2016 - 10/2008
3	Ganciclovir (Cytovene)FDA LinkGeneric 02/2015 - 05/2010
3	LuciferasesIBA 08/2012 - 07/2004
3	IodidesIBA 07/2007 - 07/2002
2	MetalsIBA 11/2023 - 01/2018
2	PorphyrinsIBA 11/2023 - 09/2021
2	CorticosteroneIBA 01/2023 - 01/2022
2	BoronIBA 10/2022 - 12/2020
2	benzothiazoleIBA 10/2022 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2018
2	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 01/2022 - 12/2014
2	Contrast MediaIBA 01/2021 - 12/2014
2	LigandsIBA 12/2020 - 04/2018
2	ThymidineIBA 02/2020 - 01/2017
2	carbopol 940 (sodium polyacrylate)IBA 01/2020 - 04/2018
2	gadolinium oxide (gadolinia)IBA 01/2020 - 04/2018
2	AntibodiesIBA 01/2020 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2018
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2019 - 12/2010
2	Trastuzumab (Herceptin)FDA Link 02/2019 - 01/2019
2	arginyl-glycyl-aspartic acidIBA 11/2018 - 12/2014
2	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 08/2016 - 03/2015
2	Firefly LuciferasesIBA 06/2016 - 09/2010
2	SodiumIBA 01/2016 - 04/2010
2	Fetal Proteins (Fetoprotein)IBA 02/2015 - 08/2012
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2015 - 08/2012
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2012 - 11/2004
2	NucleosidesIBA 03/2012 - 04/2010
2	fialuridineIBA 03/2012 - 05/2010
2	Ethanol (Ethyl Alcohol)IBA 10/2011 - 03/2010
2	ProstaglandinsIBA 03/2011 - 03/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2011 - 03/2010
2	Small Interfering RNA (siRNA)IBA 12/2010 - 12/2010
2	ProdrugsIBA 09/2010 - 04/2010
2	IodineIBA 04/2010 - 09/2004
2	LipofectamineIBA 10/2006 - 09/2004
1	alpha- Manp(1- 3)- (beta- GlcpNAc(1- 4))- (alpha- Manp(1- 6))- beta- Manp(1- 4)- beta- GlcpNAc(1- 4)- (alpha- Fucp(1- 6))- GlcpNAc (MGMM)IBA 01/2024
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2023
1	Phosphates (Orthophosphate)IBA 01/2023
1	2- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA 01/2023
1	protoporphyrin IXIBA 12/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2022
1	Photosensitizing Agents (Photosensitizers)IBA 12/2022
1	64Cu-DOTA-trastuzumabIBA 12/2022

Therapy/Procedure

23	Therapeutics 01/2023 - 07/2004
7	Radiotherapy 01/2023 - 08/2015
4	Precision Medicine 12/2021 - 01/2018
4	Neutron Capture Therapy 09/2021 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2020 - 04/2010
3	Intravenous Injections 01/2023 - 10/2014
3	Radioimmunotherapy 10/2019 - 01/2016
2	Boron Neutron Capture Therapy 10/2022 - 12/2020
2	Gamma Cameras (Gamma Camera) 12/2011 - 09/2004
2	Traditional Medicine (Folk Remedies) 10/2011 - 03/2010
1	Ligation 01/2024
1	Photochemotherapy (Photodynamic Therapy) 12/2022